MedTrace Logo

Dextromethorphan Added on for Children With Chronic Irritability

NCT05043805 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2023-04-12

No results posted yet for this study

Summary

Dextromethorphan Added on for Children With Chronic Irritability

Conditions

  • Irritable Mood

Interventions

DRUG

Dextromethorphan

add on therapy

OTHER

placebo

add on therapy

Sponsors & Collaborators

  • Tri-Service General Hospital

    lead OTHER

Principal Investigators

  • Chin-Bin Yeh, M.D., Ph.D. · Tri-Service General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
7 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-09
Primary Completion
2024-04-05
Completion
2024-06-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05043805 on ClinicalTrials.gov